Join the Fentanyl Transdermal group to help and get support from people like you.
Fentanyl Transdermal News (Page 2)
One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUD
WEDNESDAY, Nov. 8, 2023 – For individuals with opioid use disorder (OUD) using fentanyl, a one-day induction of extended‐release buprenorphine is a feasible treatment approach, according to a study p...
Concurrent Use of Fentanyl, Stimulants Common in Overdoses
FRIDAY, Sept. 15, 2023 – By 2021, stimulants were the most common drug class found in fentanyl-involved overdoses, according to a study published online Sept. 13 in Addiction. Joseph Friedman,...
Fatal ODs Involving Fentanyl Plus Coke, Meth Rose 50-Fold Over a Decade
THURSDAY, Sept. 14, 2023 – The "fourth wave" of the U.S. overdose crisis involves the use of illicit fentanyl mixed with stimulants such as cocaine or methamphetamine, and it’s killing people in d...
Overdose Deaths Involving Counterfeit Pills Increasing in U.S.
WEDNESDAY, Sept. 6, 2023 – There has been an increase in the percentage of drug overdose deaths with evidence of counterfeit pill use in the United States, according to a study published in the...
New Opioids Are Joining the Illicit Drug Supply, and They're More Potent Than Fentanyl
TUESDAY, Sept. 5, 2023 – In recent years, the opioid epidemic has been worsened by the advent of street fentanyl, an illicit version of a powerful prescription painkiller. But experts now warn that...
Counterfeit Pills Fuel Rising Number of Fatal Drug Overdoses
FRIDAY, Sept. 1, 2023 – A growing number of overdose deaths in the United States involve counterfeit pills, health officials reported Thursday. Overdose deaths involving counterfeit pills were twice...
Narcan Will Reach Drug Store Shelves Next Week
WEDNESDAY, Aug. 30, 2023 – Narcan (naloxone), a lifesaving medication that reverses opioid overdose, will be available on U.S. drugstore shelves and online starting next week. People who want to...
1 in 10 ICU Patients With Heart Issues Has Illicit Drugs in Their System
FRIDAY, Aug. 18, 2023 – More than 1 out of every 10 patients who land in an ICU with a potentially deadly heart emergency test positive for recreational drug use, a new French study reports. About...
Prevalence of Recreational Drug Use 11 Percent in Cardiac ICUs
FRIDAY, Aug. 18, 2023 – For patients hospitalized in intensive cardiac care units (ICCUs), the prevalence of recreational drug use is 11 percent, according to a study published online Aug. 15 in...
Two-Thirds of Americans Say Their Lives Have Been Affected by Addiction: Poll
TUESDAY, Aug. 15, 2023 – Millions of Americans are addicted to drugs or alcohol, and millions more struggle with an addicted family member or friend, a new poll finds. Two-thirds of those surveyed...
Most People Initiating Opioid Rx Have Very Low Use Trajectory
MONDAY, Aug. 14, 2023 – Most adults initiating treatment with prescription opioids have relatively low and time-limited exposure to opioids during a five-year period, according to a study published...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen, and Tulum for irregular pill sales. Last spring, the United...
After U.S. Warns of Counterfeit Pills Laced With Fentanyl, Mexico Shuts Down 23 Pharmacies
WEDNESDAY, Aug. 9, 2023 – Following a four-day raid, Mexico has closed 23 pharmacies in Caribbean resorts of Cancun, Playa del Carmen and Tulum for irregular pill sales. Last spring, the United...
FDA Medwatch Alert: Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error
April 27, 2023, Parsippany, NJ – Teva Pharmaceuticals USA, has initiated a voluntary nationwide recall of specific lots of various strengths of Fentanyl Buccal Tablets CII to the Consumer Level....
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
Ask a question
To post your own question to this support group, sign in or create an account.